Bo Jin
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Treatments and Mutations 27
- Lung Cancer Diagnosis and Treatment 11
- Gastric Cancer Management and Outcomes 8
- Prostate Cancer Diagnosis and Treatment 4
- Oncology 29
- Lung Cancer Research Studies 11
- Inflammatory Biomarkers in Disease Prognosis 6
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Baohui Han (22 shared papers)Jianlin Xu (12 shared papers)Yanwei Zhang (10 shared papers)Yuqing Lou (12 shared papers)Xiujuan Qu (18 shared papers)David J. Handelsman (4 shared papers)Xueyan Zhang (9 shared papers)Mingfang Zhao (10 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)BMC Cancer (5 papers)PLoS ONE (4 papers)Journal of Thoracic Oncology (4 papers)Tumor Biology (3 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Bo Jin
68 papers receiving 990 citations
Peers
Comparison fields: 5 of 71
- Pulmonary and Respiratory Medicine 547
- Oncology 359
- Cancer Research 95
- Urology 29
- Molecular Biology 157
Countries citing papers authored by Bo Jin
This map shows the geographic impact of Bo Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Jin more than expected).
Fields of papers citing papers by Bo Jin
This network shows the impact of papers produced by Bo Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Jin. The network helps show where Bo Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 102 | |
| 2 | 2016 | 78 | |
| 3 | 2017 | 73 | |
| 4 | 1999 | 54 | |
| 5 | 2017 | 49 | |
| 6 | 2021 | 48 | |
| 7 | 2012 | 42 | |
| 8 | 2019 | 33 | |
| 9 | 2017 | 30 | |
| 10 | 2015 | 22 | |
| 11 | 2014 | 21 | |
| 12 | 2010 | 21 | |
| 13 | 2014 | 19 | |
| 14 | 2015 | 19 | |
| 15 | 2016 | 17 | |
| 16 | 2015 | 17 | |
| 17 | 2016 | 17 | |
| 18 | 2023 | 16 | |
| 19 | 2014 | 16 | |
| 20 | 2014 | 15 |
About Bo Jin
Bo Jin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 70 papers that have together received 997 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Diagnosis and Treatment (11 papers), Lung Cancer Research Studies (11 papers), Gastric Cancer Management and Outcomes (8 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (547 citations), Oncology (359 citations), Cancer Research (95 citations), Urology (29 citations) and Molecular Biology (157 citations). Bo Jin has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Baohui Han, Jianlin Xu, Yanwei Zhang, Yuqing Lou, Xiujuan Qu, David J. Handelsman, Xueyan Zhang, Mingfang Zhao, Yu Dong and Jingdong Zhang. Their work appears in journals such as Journal of Clinical Oncology, BMC Cancer, PLoS ONE, Journal of Thoracic Oncology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.